CIDRAP newsletters options
"Make no mistake, we have a long way to go. This virus will be with us for a long time," says the WHO director.
Two deaths in early February in Santa Clara County, California, can now be attributed to COVID-19.
The World Health Organization (WHO) today provided more details on a yellow fever outbreak in Ethiopia, which it first noted last week in a weekly report from its African regional office.
On Mar 3, the country's health officials reported the first three suspected cases in rural Gurage zone, involving a father, mother, and son in the same household. Samples from two of the three were confirmed as positive.
Broad-spectrum antibiotics are often given to patients not infected with drug-resistant bacteria.
The global total tops 2.5 million cases, including 175,812 deaths.
At-risk children may be especially affected by COVID-related school closings and other steps.
South Carolina, Tennessee, and Georgia are reopening parts of their economies this week and next—earlier than the White House recommends.
Middle East respiratory syndrome (MERS) vaccines in England and Germany have demonstrated safety and immune response in phase 1 trials, becoming the second and third such vaccines to do so, according to studies yesterday in The Lancet Infectious Diseases.
Two studies highlight concerns about the potential to spread superbugs from pets to people.
"The continuation of this positive trend depends on our actions."
A study in healthcare workers underscores the need for careful screening.
The WHO pushes back on accusations that it didn't warn countries early enough.
An influenza research network established by the National Institutes of Health (NIH) in 2007 to help answer key questions during outbreaks now has a response plan to help it prepare for new challenges. A team led by the Centers for Infectious Disease Research and Development (CIDRAP), which publishes CIDRAP News, detailed the plan yesterday in Influenza and Other Respiratory Viruses.
New testing studies reveal more about spread in some US communities, and overseas, cases rose steadily in many countries, especially Russia and Japan.
Yesterday was the deadliest day yet in the US outbreak, with 4,951 new deaths.
Part of the problem is too few novel antibiotic candidates, according to Pew.
As global deaths approach 150,000, the WHO says it will issue guidance over the weekend on serologic testing.
The Democratic Republic of the Congo (DRC) has tracked two new Ebola cases, raising the outbreak's resurgence total to five cases that have emerged just as the country was poised to announce an end to an outbreak that began in August 2018.
Laboratory-confirmed influenza activity in the United States is now low, and influenza-like illness (ILI) activity is lower but still elevated, the Centers for Disease Control and Prevention (CDC) said today in its latest FluView report.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Antibiotic use in Chinese hospitals rose by nearly 40% from 2011 through 2018, with a troubling rise in the use of last-resort antibiotics, according to a study this week in Antimicrobial Resistance and Infection Control.
